The Shady World of Shock Treatment - Mad In America
The risk of shock treatment remains. The FDA warns that "the long-term safety and effectiveness of ECT treatment has not been demonstrated.”
Stay updated with breaking news from Mecta Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The risk of shock treatment remains. The FDA warns that "the long-term safety and effectiveness of ECT treatment has not been demonstrated.”
Monday, December 21, 2020 In a year where the use of “unprecedented” became routine, COVID-19 dominated just about every aspect of life, and its impact on drug and device law was no less encompassing. As we bid adieu and good riddance to 2020, we pause, once again, to reflect on the most significant legal developments for our drug and device clients this year. Below is a brief recap and assessment of our top five developments in drug and device law for the year. 1. Snap Removal Continues Its Momentum In April, the Fifth Circuit Court of Appeals joined the Second and Third Circui...